Making the connection between family planning and global sustainability.

WCG is an international non-profit organization committed to empowering, educating and enabling women and girls to make informed choices and access critical reproductive health products and services. WCG’s credentials in product introduction have made it a preferred partner of organizations looking to move products from laboratories and manufacturing plants to the women who need them. WCG excels at forming strategic partnerships to introduce and create access to new contraceptive methods around the world. WCG’s quality and regulatory departments are experienced in the global registration of drugs and devices, and in aiding manufacturers to improve their processes to meet international best practices. We create options for women when it comes to their reproductive health — no matter where they live.

Mission

Empower and enable women and girls to make informed choices about their reproductive and sexual health.

Our Leadership

WCG’s senior leadership team & board members share an unwavering commitment to women’s reproductive health information and access. As a woman-led organization, WCG is dedicated to ensuring that women around the world, regardless of location or socio-economic status have access to reproductive health solitions.

Meet the team

Shannon Bledsoe, Executive Director

Shannon Bledsoe is the Executive Director of WCG, an international non-profit organization based in San Diego, CA. She is responsible for leading overall organizational growth and strategic direction, and overseeing the quality of WCG’s programming. Ms. Bledsoe brings nearly 20 years of experience in international development, public health and reproductive rights to this role, leading programs and platforms for both large and small global non-profit organizations. +

In these leadership roles, she has raised nearly $100 million dollars to support the implementation of global programs. She has designed and managed initiatives supporting women’s reproductive health worldwide, and consulted with clients ranging from Yale University to small local organizations on social marketing and addressing barriers to access. Ms. Bledsoe led country platforms in Haiti, Cote d’Ivoire, and the Central African Republic and has worked, lived, and traveled in more than 40 countries. She has an advanced degree from the University of Melbourne, Australia and a BA from the University of California, San Diego.

Kelly Culwell, Chief Medical Officer

Dr. Culwell, the Chief Medical Officer of WCG, is also a Volunteer Assistant Clinical Professor in the Department of Obstetrics and Gynecology at the University of California, Davis and San Diego campuses. She previously served as a Medical officer with the World Health Organization, is widely published in peer reviewed journals and has developed global guidelines for clinical practice during her over 15-year career in women’s health. +

Dr. Culwell received a Bachelor’s of Science from California Lutheran University, a Medical Doctorate from the University of California, Davis and a Masters of Public Health from Northwestern University. She completed her post-graduate training in Obstetrics and Gynecology at University of California San Diego and her Family Planning Fellowship at Northwestern University. She is qualified as a Diplomat from the American Board of Obstetrics and Gynecology.

Wilberto Robles, Sr. Director, Regulatory Affairs

Wilberto has over fifteen years of professional experience in the pharmaceutical, medical device and cosmetic industry with a special focus in reproductive health products. He holds a Bachelor’s of Science in Microbiology and a Master’s in Manufacturing Competitiveness/Industrial Engineering. In 2002, Wilberto joined Wyeth as a Microbiology Scientist where he grew and held managerial positions within the microbiology laboratory and in the Compliance Department. +

Wilberto also worked in other pharmaceutical companies such as Bristol-Myers Squibb, APP Pharmaceuticals and Blu Pharmaceuticals. In these, he expanded his professional experience in Regulatory Affairs, where he held different leadership positions and took hands-on experience with International, EU, LAC and US regulations; Quality Assurance, where he supported the departmental daily activities and several Regulatory Authority inspections; Validation, where he established and improved different processes and equipment; and in Project Management, where he a lead a companywide project for the implementation of a regulatory electronic submissions system and lead due diligence activities for the acquisition of new manufacturing facilities. Mr. Robles has publications in the TOPRA International Journal for Professionals In Regulatory Affairs (Regulatory Rapporteur) and the POLITECHNÊ journal and SHPE (The Official Magazine of the Society of Hispanic Professional Engineers). He is an active member of the Drug Information Association (DIA), Regulatory Affairs Professionals Society (RAPS), and The Organization for Professionals in Regulatory Affairs (TOPRA). Mr. Robles is currently working for WCG as the Senior Director of Regulatory Affairs, in which he expanded his scope and worked on the registrations of drug products, medical devices and cosmetics in more than 120 countries (mostly in Africa, Asia, and Latin America).


Fil Buenviaje, Director, Quality Assurance

Fil Buenviaje has worked in Quality Assurance and Regulatory Affairs for more than 20 years with leadership roles in both the Medical Device and Pharmaceutical industries.   He joined WCG Cares in 2015 and is responsible for ensuring supplier quality, product quality and global regulatory compliance with relevant laws, rules and regulations. This includes Quality Management Systems, Good Manufacturing Practices, Regulatory Compliance, and Post-Market Surveillance. +

Prior to joining WCG Cares, Mr. Buenviaje served in a variety of Quality and Regulatory roles most recently as Director of Quality Assurance at Sequenom Biosciences.  He brings with him extensive experience as a Quality/Regulatory leader supporting development, manufacturing, quality and regulatory activities from his tenure at firms:  Quidel, Biosite, Genzyme Diagnostics and TÜV Product Service.  Mr. Buenviaje has achieved certifications as a European Notified Body Medical Auditor, a Canadian Medical Devices Conformity Assessment Systems (CMDCAS) Qualified Person, ISO 9001 and ISO 13485 Lead Auditor and Regulatory Affairs Certification (RAC-US).  He has also successfully obtained product registrations with U.S., Canada, European, Asia and Latin America regulatory authorities.

Matthew DeVol, Finance Director

Matthew DeVol is the Finance Director for WCG. Matthew has over 30 years of experience in accounting and financial management, and has executive-level experience in 501(c)3 organizations. Prior to joining WCG, Matthew worked as the Senior Director, Finance & Grants Administration for the La Jolla Institute for Allergy and Immunology. He has worked with San Diego by Project Concern International, furthering his work with USAID-funded international organizations on maternal and child healthcare, sanitation, water, and other donor-supported programs, prior to moving into the non-profit biotech field. Matthew is a certified C.P.A.

Ellen Thomas, Corporate Secretary

Ellen Thomas is the Corporate Secretary for WCG. Ellen has over 25 years of professional experience in board management and corporate governance, healthcare communications, global operations, marketing, thought leader engagement, global meeting/conference event management, pharmaceutical sales, continuing medical education and management consulting. +

She spent six years in pharmaceutical sales with Eli Lilly & Company, and 10 years in private sector pharmaceutical consulting where she provided strategic oversight in the design and implementation of communications, marketing, scientific, and educational programs for multiple therapeutic teams at Pfizer, Eisai, Amgen, Roche, Organon, Pharmacia, Talecris, Quintiles, and Covance. She has therapeutic experience in women’s reproductive health, CNS, anti-infectives, gastroenterology, anti-fungals, cardiology, smoking cessation, endocrinology, ophthalmology, oncology, and nephrology. She spent two and a half years working in a rural health clinic as a Peace Corps Volunteer in Niger, West Africa and has consulted with International Planned Parenthood Federation. Ms. Thomas Sullivan holds a BS degree from Michigan Technological University and an MPH from Columbia University in New York.

Saundra Pelletier, Chair

Saundra Pelletier is the founding CEO of WCG and she also the CEO of Evofem Biosciences, a biotech company focused on developing and commercializing innovative healthcare products for women. Ms. Pelletier brings extensive private sector experience in leadership, sales, domestic and international marketing, business development and life cycle management for a variety of women’s healthcare products including contraception, vaginal infectives, hormone replacement therapies and fertility. +

As a franchise leader at Searle Pharmaceuticals, Saundra brought four innovative products to market. Her roles spanned every critical function in the commercialization of products focused on women globally. She achieved many accolades for performance and revenue growth including oversight of a franchise with $250M in sales during her tenure and she has an uncanny ability to recruit and retain the top talent in the industry. As Chief Executive Officer of WCG she has secured $68.4 million in committed funding from major foundations and governmental organizations to support WCG’s programmatic activities worldwide.

Saundra is a published author and an international keynote speaker on gender issues and the economic return of investing in women. She currently serves as the Chair for the Board of Directors for Women Deliver, a leading non-profit global advocate for girls’ and women’s health, rights, and wellbeing. She is also a Director of Evofem Biosciences, Inc.

James Trussell, PhD

Dr. James Trussell joined the WCG of Directors in December 2016. Dr. Trussell is Professor Emeritus of Economics and Public Affairs and Senior Research Demographer of the Office of Population Research at Princeton University. He is also an Honorary Fellow at the University of Edinburgh. Dr. Trussell is the author or co-author of more than 350 scientific publications, primarily in the areas of reproductive health and demographic methodology. +

His recent research has been focused in 3 areas: emergency contraception, contraceptive failure, and the cost-effectiveness of contraception. Dr. Trussell received his BS in mathematics from Davidson College in 1971, a BPhil in economics from Oxford University in 1973, and a PhD in economics from Princeton University in 1975. He is a Senior Fellow at the Guttmacher Institute and a Deputy Editor at Contraception.